A recent report has described the use of the World Health Organization's FRAX equation as a first-line screening of bone metabolism alteration in the HIV-infected population.
With similar methods, the prevalence of T-scores ≤ -2.5 calculated from a nationwide calcaneal QUS screening of bone mass of healthy Japanese women in the sixth, seventh, or eighth-and-older decades were 5.2%, 18.7% and 43.6%, respectively [ 11]; the prevalence of low QUS values (T-scores ≤ = 2.5) in Taiwanese women were 7.9, 21.7 and 34.5%, respectively [ 13].
Milwid JM, Elman JS, Li M, Shen K, Manrai A, Gabow A, Yarmush J, Jiao Y, Fletcher A, Lee J, Cima MJ, Yarmush ML, Parekkadan B. Enriched protein screening of human bone marrow mesenchymal stromal cell secretions reveals MFAP5 and PENK as novel IL-10 modulators.
Using large-scale screening of human bone marrow stromal cell (BMSC) cDNA library, we isolated a full-length cDNA of 1352 bp encoding 380 amino acids with a ubiquitin domain (UBQ), which was designed as bone marrow stromal cell-derived ubiquitin-like protein (BMSC-UbP).
No BRAF K601N mutations were detected by AS-PCR screening of 190 bone marrow biopsies.
QUS measurement of the calcaneus may be an effective, acceptable, and useful tool for epidemiologic screening of low bone mass at a primary care units, especially those in areas where DXA is not available.
There are currently no standard recommendations for screening of metabolic bone disease and rickets in preterm infants [ 11] nor are data available describing the usual values of APA or serum P in extremely low birth weight infants (ELBW, <1000 g BW).
Finally, we screened a series of bone marrow samples from patients with AML or MDS by methylation-sensitive PCR (MS-PCR).
Results were virtually identical in secondary models that were also adjusted for mammography subsequent to the screening phase, history of bone fracture after age 45 years, and history of osteoporosis (0.87; 95% CI = 0.74 to 1.02; p = 0.22).
To explore the DNA damage accrual in different stem and progenitor cell populations during healthy aging, we screened for bone marrow samples of elderly individuals (>70 years) characterized by a good health status, notably without any chronic diseases.
